Enzymatically responsive nanocarriers targeting PD-1 and TGF-β pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy
靶向PD-1和TGF-β通路的酶响应性纳米载体可逆转免疫治疗耐药性并产生强大的治疗效果。
期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-025-03129-z
Yen, Ying-Tzu; Zhang, Zhifan; Chen, Anni; Qiu, Yuling; Liu, Qin; Wang, Qin; Li, Chunhua; Wang, Chun; Qian, Xiaoping; Shao, Jie; Meng, Fanyan; Yu, Lixia; Liu, Baorui; Li, Rutian